SCLN 8.51 Sciclone Pharmaceuticals $SCLN Hit a 52

SCLN 8.51 Sciclone Pharmaceuticals $SCLN Hit a 52 week high of 8.53 Closing the day 09:44 at 8.51 +0.08 +0.95% With a day low of 8.22 and a total volume of 129,826.

SCLN Recent Posts: http://investorshangout.com/Sciclone-Pharmace...CLN-55380/

SCLN Sciclone Pharmaceuticals Recent Headline News

Update: SciClone Pharmaceuticals Exceeds Earnings Estimates For Q3
David Zanoni - at Seeking Alpha - Sat Nov 15, 12:21AM CST

SCLN: 8.40 (-0.03)

Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 55.2% (SCLN)
Comtex SmarTrend(R) - Fri Nov 14, 4:46PM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 3 months, Sciclone Pharmaceuticals has returned 55.25% as of today's recent price of $8.43.
SCLN: 8.40 (-0.03)

SciClone reports lower Q3 2014 GAAP net income of USD7.9m
M2 - Wed Nov 12, 7:18AM CST
Pharmaceutical company SciClone Pharmaceuticals (NasdaqGS:SCLN) disclosed on Tuesday its GAAP net income of USD7.9m (USD0.16 & USD0.15 per share, basic and diluted, respectively) for the Q3 2014.
SCLN: 8.40 (-0.03)

SciClone Pharma ups earnings guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:47AM CST

SCLN: 8.40 (-0.03)

SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 8:47PM CST

SCLN: 8.40 (-0.03)

SciClone Pharmaceuticals (SCLN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST

SCLN: 8.40 (-0.03)

SciClone Pharmaceuticals beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:16PM CST

SCLN: 8.40 (-0.03)

SciClone Reports Financial Results for the Third Quarter 2014
Marketwired - Mon Nov 10, 3:06PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter 2014.
SCLN: 8.40 (-0.03)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST

HK: 3.03 (-0.07), WWD: 51.55 (+0.52), LLNW: 2.62 (-0.03), FXEN: 2.63 (-0.09), RMTI: 10.54 (+0.02), CZR: 15.76 (-0.74), EGY: 6.50 (-0.56), ICUI: 86.78 (+1.07), ICEL: 7.15 (-0.44), SAAS: 8.65 (-0.09), DMD: 5.50 (-0.15), NPSP: 29.59 (+0.59), SCLN: 8.40 (-0.03), ATHX: 1.38 (+0.01), CMLS: 3.58 (-0.08), TC: 2.05 (+0.02), ATW: 36.09 (+0.61), CLUB: 5.64 (-0.02), RAX: 42.77 (-0.48), PTLA: 26.47 (-0.10), IPAR: 26.94 (-0.68), ATLS: 35.98 (-0.11), AMBC: 25.89 (-0.59), CUI: 7.00 (-0.02), PDLI: 7.92 (+0.13), OMER: 19.29 (+0.31), PRAA: 59.07 (-0.92), CARA: 8.38 (-0.02), HALO: 8.60 (+0.06), MODN: 10.17 (-0.20), CALL: 8.84 (+0.22), ASEI: 46.24 (+0.12), HGR: 18.52 (-2.68), ERII: 4.65 (-0.01)

Sciclone Pharmaceuticals Has Returned 41.6% Since SmarTrend Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Nov 07, 10:59AM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 3 months, Sciclone Pharmaceuticals has returned 41.62% as of today's recent price of $7.69.
SCLN: 8.40 (-0.03)

SciClone to Present at Jefferies Global Healthcare Conference on November 19th
Marketwired - Thu Nov 06, 5:00AM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the Jefferies Global Healthcare Conference on November 19, 2014, at 4:20 pm GMT, taking place at the Waldorf Hilton Hotel in London, England.
SCLN: 8.40 (-0.03)

SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th
Marketwired - Thu Oct 30, 5:01AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2014 on Monday, November 10, 2014. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call will be hosted by Friedhelm Blobel, Ph.D., President and CEO, and Wilson W. Cheung, Senior Vice President and CFO.
SCLN: 8.40 (-0.03)

Sciclone Pharmaceuticals Shares Up 44.4% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Oct 24, 9:09AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 44.38% as of today's recent price of $7.84.
SCLN: 8.40 (-0.03)

3 Biotech Stocks Near 52-Week Highs Worth Selling
Motley Fool Staff - Motley Fool - Wed Oct 22, 12:01PM CDT
With markets dropping-and-popping this month investors are right to wonder whether rising volatility means that it's a good time to be moving out of high flying stocks. But just because a stock is hitting new highs doesn't mean that it isn't a great...
MACK: 8.73 (+0.25), BCRX: 10.19 (+0.12), BAX: 71.69 (-0.06), SCLN: 8.40 (-0.03), GSK: 45.83 (+0.09), CELG: 104.48 (+0.43)

Sciclone Pharmaceuticals Shares Up 26.7% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Thu Oct 09, 11:01AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 26.70% as of today's recent price of $6.88.
SCLN: 8.40 (-0.03)

Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 27.3% (SCLN)
Comtex SmarTrend(R) - Thu Oct 02, 9:42AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 27.26% as of today's recent price of $6.91.
SCLN: 8.40 (-0.03)